A science review is only as useful as the people conducting it. Dr. John E. Hall and Dr. Kenneth M. Yates have a credential most reviewers don't: they were part of the original team at Carrington Laboratories that first identified and isolated acemannan from Aloe vera. Between them, over 70 years of research experience with this specific compound. Dr. Yates served as founding president of Carrington's subsidiary DelSite Biotechnologies. Dr. Hall worked directly under Dr. Bill McAnalley, the scientist who first isolated acemannan.
almä commissioned their review in 2026. What follows is a summary of the findings — and a clear picture of the acemannan benefits that are actually backed by evidence, versus what's just marketing language.
Acemannan Is a Nutrient, Not a Drug
Before getting into the findings, it helps to answer what is acemannan at a basic level. It's a beta-linked long-chain polysaccharide found in the inner gel of Aloe vera. The review establishes an important framing point early. Despite the range of studied activities, Hall and Yates classify acemannan as a nutrient — comparable to a vitamin or essential fatty acid — rather than a treatment.
The distinction matters. Nutrients work by supporting normal biological function, not by overriding it. The review's consistent observation is that acemannan helps the body do what it was designed to do: support immune cells already present, feed gut bacteria that already exist, and activate cellular processes that are supposed to run.
This framing also explains why acemannan's effects are broad rather than targeted at a single symptom. It operates across biological systems that share common underlying processes.
What the Immune Research Describes
The review covers acemannan's most studied area: its effects on immune cells.
- Macrophage activation. Macrophages are the largest population of immune cells in the body. They're present throughout the GI tract, where they handle everything from pathogen surveillance to normal gut motility. Their cell membranes carry several receptor types that recognize acemannan, including mannose receptors. The review notes this points to a close structural fit between the compound and these cells. When acemannan binds to these receptors, research suggests it may stimulate and activate the cell.
- T-cell regulation. Studies cited in the review show acemannan may activate healthy T-cells while inhibiting the growth of cancerous T-cells.
- Cytokine storm suppression. Cytokine storm is a dangerous immune overreaction, where excessive inflammatory signals spread through the body. A recent study cited in the review found acemannan may help suppress it by regulating macrophage behavior and mitochondrial metabolism.
- Dendritic and cytotoxic T-cell activity. Research suggests acemannan may help dendritic cells mature. These cells capture pathogens and trigger immune responses. Acemannan may also directly stimulate cytotoxic T-cells that target infected or damaged cells.
Gut Health: Prebiotic Activity
Because acemannan is a beta-linked long-chain polysaccharide, digestive enzymes don't break it down. It reaches the lower small intestine and colon largely intact, where specific gut bacteria — containing mannanase and related enzymes — metabolize it into short-chain fatty acids.
The review describes this as prebiotic activity:
- Studies cited show acemannan may increase acetate concentrations and stimulate the growth of Bifidobacterium species.
- The review also cites a randomized crossover study in obese men. Adding 1g of ethanol-precipitated acemannan to aloe vera juice may have lowered post-meal glucose and triglycerides, and boosted antioxidant activity, compared to controls.
Antioxidant Activity and Mitochondrial Support
The review notes that oxidative stress is now recognized as a contributing factor across virtually all chronic disease states. Oxidative stress means excess reactive oxygen species (ROS) building up in cells and tissues.
In cell studies, acemannan has been shown to reduce ROS levels and may help limit mitochondrial dysfunction in colonic epithelial cells. A separate study found acemannan may promote cell recovery in fibroblasts damaged by oxidative exposure.
Protecting mitochondrial function matters because mitochondria do more than produce energy. They also handle cell signaling, metabolism, and apoptosis — the process that clears out damaged or aged cells.
The Quality Problem: What Blind Testing of 32 Products Found
One of the review's most important findings concerns commercial product quality. A study cited in the review (Turner et al., 2004) tested 32 aloe vera raw materials blindly for molecular weight using size exclusion chromatography. Nearly all returned significantly lower molecular weights than found naturally in the plant.
Molecular weight determines which acemannan functions are possible:
- Large molecules interact with macrophage receptors in the gut wall.
- Smaller fragments may serve as prebiotic substrate in the colon.
- Fragmented, low-molecular-weight material doesn't reliably replicate either function — and standard "aloe vera" labeling doesn't require molecular weight disclosure.
This is exactly the kind of gap that matters when comparing a generic aloe vera product to a verified acemannan supplement.
The review confirms that almä's process — ethanol precipitation followed by freeze-drying — preserves the broad range of acemannan molecular weights that occur naturally. It further notes that most of the research studies cited in the review describe obtaining acemannan via ethanol precipitation, using a lab method similar to almä's.
Aloe Pectin: The Other Active Compound
The review also covers aloe pectin, a unique fiber found in aloe vera's inner gel. Like acemannan, aloe pectin requires ethanol precipitation to preserve its high molecular weight.
Studies cited describe its potential to:
- Support gut barrier function
- Act as a prebiotic
- Provide antioxidant activity
- Interact with intestinal flora in ways that may influence GLP-1 release
The review characterizes acemannan and aloe pectin together as the basis for aloe vera's long-standing reputation across traditional medicine systems.
What This Review Means
Science reviews don't produce new data. They assess what accumulated evidence shows. The Hall and Yates review is significant because of who authored it and what it covers. It surveys the full range of acemannan benefits studied to date, evaluated by two scientists with direct involvement in its original discovery, and it gives a clear finding on what the quality standard requires.
The research only applies if the product actually matches the compound studied. For those evaluating an acemannan supplement — or comparing acemannan capsules in general — the molecular weight and verification standard described in this review is the benchmark to apply. See the acemannan page for a breakdown of how its molecular structure and verification are assessed. See the extraction process page for more on how it preserves the molecular profile this research describes.
FAQ
What is acemannan? Acemannan is a beta-linked long-chain polysaccharide found in the inner gel of Aloe vera. According to the Hall and Yates review, it is classified as a nutrient rather than a drug, and is the compound behind most of aloe vera's studied immune, gut, and antioxidant activity.
Who authored the almä 2026 science review? Dr. John E. Hall and Dr. Kenneth M. Yates — two scientists who were part of the original research team at Carrington Laboratories that first identified and isolated acemannan from Aloe vera. Both have over 35 years of research experience with acemannan specifically.
What does the 2026 acemannan science review cover? The review covers acemannan's studied activities across immune function, gut health (prebiotic activity, gut barrier support), antioxidant activity, mitochondrial function, wound healing, and apoptosis regulation. It also evaluates commercial product quality standards, citing blind testing of 32 aloe raw materials.
What did the blind test of 32 aloe products find? Nearly all of the 32 aloe vera raw materials tested (Turner et al., 2004) returned significantly lower molecular weights than found naturally in the aloe plant. Molecular weight is a key determinant of acemannan's biological activity, and most commercial products — including many acemannan capsules on the market — do not disclose or verify this measurement.
Is acemannan considered a drug? According to the Hall and Yates review, acemannan is classified as a nutrient — not a drug or therapeutic agent. It supports normal biological function rather than overriding it. These statements have not been evaluated by the FDA. almä products are not intended to diagnose, treat, cure, or prevent any disease.
What extraction method does the acemannan research use? Most acemannan research studies, including human clinical trials, use ethanol-precipitated fractions. This is the same method almä uses for its True Acemannan extraction process.
Disclaimer: The information in this article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement or wellness routine.
References
Hall, J.E. & Yates, K.M. (2026). Aloe, Acemannan and Aloe Pectin: A Review. Commissioned by almä True Acemannan.
Talmadge, J., et al. (2004). Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity. International Immunopharmacology, 4(14), 1757–1773.
Turner, C.E., et al. (2004). Evaluation and comparison of commercially available Aloe vera L. products using size exclusion chromatography. International Immunopharmacology, 4(14), 1727–1737.
Bai, Y., Niu, Y., Qin, S., & Ma, G. (2023). Acemannan from basic studies to clinical application. Pharmaceutics, 15(7), 1913.
Sánchez, M., et al. (2020). Pharmacological update properties of Aloe vera and its major active constituents. Molecules, 25(6). View study
Sadgrove, N. J., & Simmonds, M. S. J. (2021). Pharmacodynamics of Aloe vera and acemannan in therapeutic applications for skin, digestion, and immunomodulation. Phytotherapy Research, 35(12), 6572–6584.